Tomas Majtan

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Body Composition

Replacement Therapy

Endoplasmic Reticulum

Endothelial Cells

Top Venues

Protein science : a publication of the Protein Society

This page only lists publications with an associated author ORCID identifier.

Publications

Ela Mijatovic, Kelly Ascenção, Csaba Szabo, Tomas Majtan
Cellular turnover and degradation of the most common missense cystathionine beta-synthase variants causing homocystinuria. Protein science : a publication of the Protein Society 33 (8) (2024)
Ela Mijatovic, Kelly Ascenção, Csaba Szabo, Tomas Majtan
Cellular turnover and degradation of the most common missense cystathionine beta-synthase variants causing homocystinuria. Protein science : a publication of the Protein Society 33 (8) (2024)
Ela Mijatovic, Kelly Ascenção, Csaba Szabo, Tomas Majtan
Cellular turnover and degradation of the most common missense cystathionine beta-synthase variants causing homocystinuria. Protein science : a publication of the Protein Society 33 (8) (2024)
Viktor Kožich, Tomas Majtan
Komrower Memorial Lecture 2023. Molecular basis of phenotype expression in homocystinuria: Where are we 30 years later? Journal of inherited metabolic disease (2024)
Renata Collard, Tomas Majtan
Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants. Molecular and cellular biology (2023)
Tomas Majtan, Viktor Kožich, Warren D Kruger
Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria. British journal of pharmacology (2022)
Maria Petrosino, Karim Zuhra, Jola Kopec, Andrew Hutchin, Csaba Szabo, Tomas Majtan
H 2 S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine. Cellular and molecular life sciences : CMLS 79 (8) (2022)
Insun Park, Linda K Johnson, Allaura Cox, Brian R Branchford, Jorge Di Paola, Erez M Bublil, Tomas Majtan
Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria. Biomedicines 8 (8) (2020)
Insun Park, Erez M Bublil, Frank Glavin, Tomas Majtan
Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria. Nutrients 12 (9) (2020)
Insun Park, Helena Hůlková, Jakub Krijt, Viktor Kožich, Erez M Bublil, Tomas Majtan
Long-term uninterrupted enzyme replacement therapy prevents liver disease in murine model of severe homocystinuria. Human mutation 41 (9) (2020)
Tomas Majtan, Insun Park, Erez M Bublil, Jan P Kraus
Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria. Human mutation 39 (2) (2017)
Tomas Majtan, Insun Park, Richard S Carrillo, Erez M Bublil, Jan P Kraus
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria. Biomacromolecules 18 (6) (2017)